Page last updated: 2024-12-07

6-deoxyglucose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-deoxyglucose is a glucose analog that lacks a hydroxyl group at the 6-position. It is a potent inhibitor of glucose metabolism, primarily acting as a competitive inhibitor of hexokinase, the enzyme responsible for the first step in glucose phosphorylation. 6-deoxyglucose is actively transported into cells by glucose transporters, but it cannot be further metabolized due to the absence of the hydroxyl group. Its accumulation within cells leads to a depletion of ATP and inhibition of glycolysis. This property makes 6-deoxyglucose a valuable tool for studying glucose metabolism and its role in various cellular processes. In research, it has been utilized to investigate the involvement of glucose metabolism in cancer cell proliferation, neuronal function, and insulin signaling. 6-deoxyglucose has also been explored as a potential therapeutic agent for treating diabetes, cancer, and neurodegenerative diseases.'

6-deoxyglucose: RN given refers to (D)-isomer; Main Heading DEOXYGLUCOSE refers to 2-deoxyglucose [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93579
SCHEMBL ID59278
MeSH IDM0114397

Synonyms (21)

Synonym
7658-08-4
6-deoxyglucose
6dog
(3r,4s,5s)-3,4,5-trihydroxy-2-oxohexanal
(2r,3s,4r,5r)-2,3,4,5-tetrahydroxyhexanal
unii-o654621e3t
o654621e3t ,
einecs 231-622-2
d-isorhamnose
epifucose
chinovose
d-epirhamnose
quinovose [mi]
SCHEMBL59278
PNNNRSAQSRJVSB-JGWLITMVSA-N
aldehydo-d-quinovose
AKOS027446289
Q3414551
STR01510
AMY41560
DTXSID701032788
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quinovoseA deoxyglucose that is glucose in which the hydroxy group at position 6 has been replaced by a hydrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (27.03)18.7374
1990's13 (35.14)18.2507
2000's6 (16.22)29.6817
2010's6 (16.22)24.3611
2020's2 (5.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.53 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]